Cover Image
Market Research Report

Global Implantable Cardioverter Defibrillators (ICD) Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 759938
Published Content info 114 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Implantable Cardioverter Defibrillators (ICD) Market 2018-2022
Published: December 12, 2018 Content info: 114 Pages
Description

About this market:

Technological advances to drive growth in the market. Technological advances such as the introduction of quadripolar lead devices, improvements in patient monitoring to avoid needless shocks, and development of MRI safe ICDs have significantly improved the reliability and effectiveness of ICDs. Technavio's analysts have predicted that the implantable cardioverter defibrillators market will register a CAGR of almost 2% by 2022.

Market Overview:

Increasing prevalence of cardiac arrhythmias

Prevalence of cardiac arrhythmias is steadily increasing. With the rise in cardiac disorders the demand for implantable cardioverter defibrillators will also increase.

Device limitations and complications

ICDs have been associated with many undesirable effects such as lead failures, deterioration in the quality of life, repeated in appropriate shocks, and premature battery complications.

For the detailed list of factors that will drive and challenge the growth of the implantable cardioverter defibrillators market during the 2018-2022, view our report.

Competitive Landscape:

The market appears to be fragmented and with the presence of several companies including Abbott and BIOTRONIK the competitive environment is quite intense. Factors such as the technological advances and the increasing prevalence of cardiac arrhythmias, will provide considerable growth opportunities to implantable cardioverter defibrillators manufactures. Abbott, BIOTRONIK, Boston Scientific, and Medtronic are some of the major companies covered in this report.

Table of Contents
Product Code: IRTNTR23814

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Regular ICD
  • CRT-D
  • S-ICD
  • Market opportunity by product
  • PART 08: MARKET SEGMENTATION BY END-USER
  • Hospitals and clinics
  • ASCs

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • ICD market in Americas
  • ICD market in EMEA
  • ICD market in APAC
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Technological advances
  • Increasing popularity of remote monitoring and follow-up of ICDs

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • BIOTRONIK
  • Boston Scientific
  • Medtronic

PART 16: APPENDIX

  • List of abbreviations

PART 17: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global cardiac implants market
  • Exhibit 02: Global cardiac implants market - Segments
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Global ICD market 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global ICD market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global ICD market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global ICD market - Market share by product 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global regular ICD market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global regular ICD market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global CRT-D market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global CRT-D market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Global S-ICD market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Global S-ICD market - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global ICD market - Market share by region 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: ICD market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: ICD market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top three countries in Americas
  • Exhibit 33: ICD market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: ICD market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top three countries in EMEA
  • Exhibit 36: ICD market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: ICD market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 38: Top three countries in APAC
  • Exhibit 39: Market opportunity
  • Exhibit 40: ICD new implant rates per 100,000 population between 2010 and 2015
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Abbott - Overview
  • Exhibit 47: Abbott - Business segments
  • Exhibit 48: Abbott - Organizational developments
  • Exhibit 49: Abbott - Geographic focus
  • Exhibit 50: Abbott - Segment focus
  • Exhibit 51: Abbott - Key offerings
  • Exhibit 52: Abbott - Key customers
  • Exhibit 53: BIOTRONIK - Overview
  • Exhibit 54: BIOTRONIK - Business segments
  • Exhibit 55: BIOTRONIK - Organizational developments
  • Exhibit 56: BIOTRONIK - Key offerings
  • Exhibit 57: BIOTRONIK - Key customers
  • Exhibit 58: Boston Scientific - Overview
  • Exhibit 59: Boston Scientific - Business segments
  • Exhibit 60: Boston Scientific - Organizational developments
  • Exhibit 61: Boston Scientific - Geographic focus
  • Exhibit 62: Boston Scientific - Segment focus
  • Exhibit 63: Boston Scientific - Key offerings
  • Exhibit 64: Boston Scientific - Key customers
  • Exhibit 65: Medtronic - Overview
  • Exhibit 66: Medtronic - Business segments
  • Exhibit 67: Medtronic - Organizational developments
  • Exhibit 68: Medtronic - Geographic focus
  • Exhibit 69: Medtronic - Segment focus
  • Exhibit 70: Medtronic - Key offerings
  • Exhibit 71: Medtronic - Key customers
Back to Top